A Pennsylvania woman received breast cancer treatment for 13 months before doctors discovered she had a rare and aggressive ...

Hodgkin lymphoma (formerly known as Hodgkin disease), which involves an abnormal type of lymphocyte called Reed-Sternberg cells Non-Hodgkin lymphoma, which does not contain Reed-Sternberg cells Both ...

A new study reports that the cytokine IL-17A drives malignant T-cell proliferation in cutaneous T-cell lymphoma by increasing ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Hodgkin lymphoma (HL) is a treatable cancer with an incidence peak in adolescent and young adult years. Treatment strategies have been developed to balance the intensity of therapy needed to maintain ...

The Partita CRISPR activation library identified Irx5 as a gene linked to venetoclax resistance and Runx2, Runx3 and Csf1r as ...

Shanghai Junshi Biosciences (SEHK:1877) reported first patient dosing in a new phase 3 trial of JS207/JS007 for advanced ...

Lymphoma is a type of blood cancer that targets the lymphatic system. This type of cancer impacts the cells that are a part of one's immune system, according to the American Cancer Society. There are ...

The results apply to 93 adult patients with aggressive B-cell lymphoma (ABCL) treated between 2019 and 2024. Of these, 66% achieved complete remission, meaning the cancer completely diminished, within ...

The market dynamics for Anaplastic Lymphoma Kinase-positive Non-Small Cell Lung Cancer (ALK-positive NSCLC) are witnessing ...

What is North Park University researching with its NIH grant? NPU is researching how lymphoma cells reach the brain and how the brain defends itself against them. The four-year project, led by Dr.